Jocelyn T. Kim

1.4k total citations · 1 hit paper
24 papers, 892 citations indexed

About

Jocelyn T. Kim is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Jocelyn T. Kim has authored 24 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 9 papers in Infectious Diseases and 9 papers in Immunology. Recurrent topics in Jocelyn T. Kim's work include HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (8 papers) and HIV/AIDS drug development and treatment (5 papers). Jocelyn T. Kim is often cited by papers focused on HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (8 papers) and HIV/AIDS drug development and treatment (5 papers). Jocelyn T. Kim collaborates with scholars based in United States, China and Poland. Jocelyn T. Kim's co-authors include David Baltimore, Alex Sigal, Alejandro B. Balazs, Avi Mayo, E. Dekel, Ron Milo, James R. Heath, Michael T. Leonard, Jessica K. Wang and Owen N. Witte and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jocelyn T. Kim

21 papers receiving 877 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy

2011 418 citations Alex Sigal, Jocelyn T. Kim et al. Nature profile →

Peers

Countries citing papers authored by Jocelyn T. Kim

Since Specialization

Citations

This map shows the geographic impact of Jocelyn T. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn T. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn T. Kim more than expected).

Fields of papers citing papers by Jocelyn T. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jocelyn T. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn T. Kim. The network helps show where Jocelyn T. Kim may publish in the future.

Co-authorship network of co-authors of Jocelyn T. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jocelyn T. Kim. A scholar is included among the top collaborators of Jocelyn T. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jocelyn T. Kim. Jocelyn T. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Author Correction: Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns 2025 ·Nature Communications ·(unknown), (unknown), Natalia L. Komarova, Dominik Wodarz, (unknown), Albert L. Gonzales, (unknown), Hongying Chen, (unknown), (unknown), William T. Harvey, (unknown), (unknown), Christopher S. Seet, Yushen Du, Ren Sun, Jerome A. Zack, Jocelyn T. Kim	0
2	Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV 2025 ·Science Advances ·(unknown), (unknown), (unknown), (unknown), Jocelyn T. Kim, Matthew D. Marsden, Jerome A. Zack, Paul A. Wender	0
3	Barcoded HIV-1 reveals viral persistence driven by clonal proliferation and distinct epigenetic patterns 2025 ·Nature Communications ·(unknown), Yuan Shi, Natalia L. Komarova, (unknown), (unknown), Albert L. Gonzales, (unknown), Hongying Chen, (unknown), (unknown), William T. Harvey, (unknown), (unknown), Christopher S. Seet, Yushen Du, Ren Sun, Jerome A. Zack, Jocelyn T. Kim	0
4	Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Alok Ranjan, Rami Hourani, Jocelyn T. Kim, Paul A. Wender, Matthew D. Marsden, Jerome A. Zack	2
5	Current Advances in Humanized Mouse Models for Studying NK Cells and HIV Infection 2023 ·Microorganisms ·Jocelyn T. Kim, (unknown), Jerome A. Zack	7
6	Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal 2023 ·Virology ·(unknown), Alok Ranjan, Rami Hourani, Jocelyn T. Kim, Paul A. Wender, Jerome A. Zack, Matthew D. Marsden	1
7	A humanized mouse model to study NK cell biology during HIV infection 2022 ·Journal of Clinical Investigation ·Jocelyn T. Kim, Jerome A. Zack	1
8	Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention 2022 ·Stem Cell Research & Therapy ·Yan-Ruide Li, Zachary Spencer Dunn, Gustavo Garcia, (unknown), Yang Zhou, Derek Lee, Jiaji Yu, (unknown), Jocelyn T. Kim, Vaithilingaraja Arumugaswami, Pin Wang, Lili Yang	23
9	Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients 2021 ·Frontiers in Immunology ·Lili Li, Jie Li, Meiling Gao, Huimin Fan, Yanan Wang, Xin Xu, Hung-Chih Chen, Junxiao Liu, Jocelyn T. Kim, Roghiyh Aliyari, Jicai Zhang, Yujie Jin, Xiaorong Li, Feng Ma, Minxin Shi, Genhong Cheng, Heng Yang	105
10	Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra 2021 ·Journal of Visualized Experiments ·(unknown), Jocelyn T. Kim, Guillermo Horga, Kenneth Wengler	9
11	Tracking HIV Rebound following Latency Reversal Using Barcoded HIV 2020 ·Cell Reports Medicine ·Matthew D. Marsden, Tianhao Zhang, Yushen Du, (unknown), Mohamed S. Soliman, Xiaomeng Wu, Jocelyn T. Kim, Akira Shimizu, Adam J. Schrier, Paul A. Wender, Ren Sun, Jerome A. Zack	19
12	Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo 2020 ·Cell Reports Medicine ·Lars Pache, Matthew D. Marsden, Peter Teriete, (unknown), (unknown), Jocelyn T. Kim, Mohamed S. Soliman, (unknown), (unknown), Maria Celeridad, Adam M. Spivak, Vicente Planelles, Nicholas D. P. Cosford, Jerome A. Zack, Sumit K. Chanda	38
13	T cell antigen discovery via trogocytosis 2019 ·Nature Methods ·Guideng Li, Michael T. Bethune, Stephanie Wong, Alok V. Joglekar, Michael T. Leonard, Jessica K. Wang, Jocelyn T. Kim, Donghui Cheng, Songming Peng, Jesse M. Zaretsky, Yapeng Su, Yicheng Luo, James R. Heath, Antoni Ribas, Owen N. Witte, David Baltimore	107
14	Dendritic cells efficiently transmit HIV to T Cells in a tenofovir and raltegravir insensitive manner 2018 ·PLoS ONE ·Jocelyn T. Kim, (unknown), Alex Sigal, David Baltimore	9
15	Dendritic cell–targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation 2017 ·Science Immunology ·Jocelyn T. Kim, Yarong Liu, Rajan P. Kulkarni, (unknown), Bingbing Dai, (unknown), Yong Ouyang, Pin Wang, Lili Yang, David Baltimore	11
16	Anaphylactic reaction secondary to topical preoperative moxifloxacin 2016 ·Journal of Cataract & Refractive Surgery ·(unknown), (unknown), Jocelyn T. Kim, Saul Ullman	9
17	Simplified three-dimensional tissue clearing and incorporation of colorimetric phenotyping 2016 ·Scientific Reports ·Kevin Sung, Yichen Ding, Jianguo Ma, (unknown), Vincent Huang, Michelle Cheng, Cindy F. Yang, Jocelyn T. Kim, (unknown), Dino Di Carlo, Tzung K. Hsiai, Atsushi Nakano, Rajan P. Kulkarni	37
18	Coenzyme Q10 in the Treatment of Corneal Edema in Kearns-Sayre 2016 ·Cornea ·Jocelyn T. Kim, (unknown), Bharesh K. Chauhan, (unknown), (unknown), (unknown), (unknown), Ken K. Nischal	13
19	A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses 2012 ·Vaccine ·Xiao Liang, Jocelyn T. Kim, (unknown), Bingbing Dai, Lili Yang, Steven G. Reed, David Baltimore, Pin Wang	12
20	Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy breakdown → 2011 ·Nature ·Alex Sigal, Jocelyn T. Kim, Alejandro B. Balazs, E. Dekel, Avi Mayo, Ron Milo, David Baltimore	418

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact